Ginkgo, Novo Nordisk forge ‘flexible’ research pact, from discovery to manufacturing
Ginkgo Bioworks is expanding its original research partnership with Novo Nordisk to cover the entire value chain.
The new pact is a “flexible and scalable” new model, the companies said in a Wednesday release. “We’ve created something where it’ll help Novo to start doing a variety of projects faster,” Aaron Schwartz, Ginkgo’s senior director of business development in biotech and pharma, told Endpoints News in an interview.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.